MedTrace Logo

Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis

NCT00971477 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2010-12-13

No results posted yet for this study

Summary

The purpose of this study is to determine if an asynchronous online model of teledermatology can achieve similar clinical outcomes as compared to conventional in-office care for the management of psoriasis. The investigators also aim to determine the effects of this online care model on patient quality of life as well as patient and physician satisfaction.

The investigators' hypotheses include the following:

1. Compared to in-person visits, the online care model will result in similar clinical improvement in psoriasis disease severity.
2. Compared to in-person visits, the online care model will result in similar improvements in quality of life.
3. Providers and subjects in the online group will achieve a similar level of overall satisfaction as those in the in-person group.

Conditions

Interventions

OTHER

Online Teledermatology Care

Patients randomized to the intervention group will have their scheduled follow-up visits online via a store and forward teledermatology modality.

OTHER

Conventional in Office Care

Patients randomized to the control group will have their scheduled follow-up visits via conventional in office care.

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • April W Armstrong, MD · UC Davis Department of Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00971477 on ClinicalTrials.gov